메뉴 건너뛰기
BJU International
Volumn 85, Issue 6, 2000, Pages 686-689
A comparison of six commercial assays for total and free prostate specific antigen (PSA): The predictive value of the ratio of free to total PSA
Author keywords

Assay methods; FPSA; Prostate specific antigen; PSA ratio
Indexed keywords

PROSTATE SPECIFIC ANTIGEN;
EID: 0034125518     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00526.x     Document Type: Article
Times cited : (26)
References (13)
  • 1
    • 0026077430 scopus 로고
    • Prostate specific antigen in serum occurs predominantly in complex with alpha-1-antichymotrypsin
    • 1 Lilja H, Christenson A, Dahlen U. Prostate specific antigen in serum occurs predominantly in complex with alpha-1-antichymotrypsin. Clin Chem 1991; 37: 1618
    • (1991) Clin Chem , vol.37 , pp. 1618
    • Lilja, H.1    Christenson, A.2    Dahlen, U.3
  • 2
    • 7844247583 scopus 로고    scopus 로고
    • Percent free prostate specific antigen in assessing the probability of prostate cancer under optimal analytical conditions
    • 2 Gion M, Mione R, Banioli P et al. Percent free prostate specific antigen in assessing the probability of prostate cancer under optimal analytical conditions. Clin Chem 1998; 44: 2462-70
    • (1998) Clin Chem , vol.44 , pp. 2462-2470
    • Gion, M.1    Mione, R.2    Banioli, P.3
  • 3
    • 0027889117 scopus 로고
    • Significance of different molecular forms of serum PSA. The free noncomplexed forms of PSA versus that complexed to alpha -1- antichymotrypsin
    • 3 Lilja, H. Significance of different molecular forms of serum PSA. The free noncomplexed forms of PSA versus that complexed to alpha -1- antichymotrypsin. Urol Clin North Am 1993; 20: 681-6
    • (1993) Urol Clin North Am , vol.20 , pp. 681-686
    • Lilja, H.1
  • 4
    • 0026027671 scopus 로고
    • A complex between prostate specific antigen and α1-antichymotrypsin is the major form of prostate specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer
    • 4 Stenman UH, Leionen J, Alfthan H et al. A complex between prostate specific antigen and α1-antichymotrypsin is the major form of prostate specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991; 51: 222-6
    • (1991) Cancer Res , vol.51 , pp. 222-226
    • Stenman, U.H.1    Leionen, J.2    Alfthan, H.3
  • 5
    • 0028125693 scopus 로고
    • Assays for prostate specific antigen (PSA): Problems and possible solutions
    • 5 Wu JT. Assays for prostate specific antigen (PSA): problems and possible solutions. J Clin Lab Ana L 1994; 8: 51-62
    • (1994) J Clin Lab Ana L , vol.8 , pp. 51-62
    • Wu, J.T.1
  • 6
    • 0030340578 scopus 로고    scopus 로고
    • Free to total prostate-specific antigen in serum is superior to total-PSA in differentiating benign prostatic hypertrophy from prostate cancer
    • 6 Vancangh PJ, Denayer P, Sauvage P et al. Free to total prostate-specific antigen in serum is superior to total-PSA in differentiating benign prostatic hypertrophy from prostate cancer. Prostate Suppl 1996; 7: 30-4
    • (1996) Prostate Suppl , vol.7 , pp. 30-34
    • Vancangh, P.J.1    Denayer, P.2    Sauvage, P.3
  • 7
    • 0029240414 scopus 로고
    • Second Stanford Conference on international standardisation of prostate specific antigen immunoassays
    • 7 Stamey TA. Second Stanford Conference on international standardisation of prostate specific antigen immunoassays. Urology 1995; 45: 173-84
    • (1995) Urology , vol.45 , pp. 173-184
    • Stamey, T.A.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.